MET and liver cancer: While increasing evidence indicates that AKT6, 7, 21 and c-Met9, 10, 11, 12 are frequently overexpressed or activated in HCCs, the functional crosstalk between the two pathways and the mechanisms whereby AKT and c-Met cooperate in liver cancer remain obscure.